サマリー

プロテアソーム阻害剤の世界市場2022-2026年
Technavioはプロテアソーム阻害剤市場を監視しており、2022-2026年の間に22億ドルの成長が見込まれ、予測期間中にCAGR7.4％で減速する見込みである。当レポートでは、プロテアソーム阻害剤市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、膨大なアンメットニーズ、強力な採用率、多発性骨髄腫の罹患率の増加によって牽引されています。
プロテアソーム阻害剤市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioのプロテアソーム阻害剤市場は、以下のように区分されています。
製品別
- ベルケイド
- キプロリス
- ニンラーロ
- その他
地域別構成比
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間におけるプロテアソーム阻害剤市場の成長を促進する主な理由の1つとして、用途の拡大を挙げています。また、特効薬の指定や発展途上国での急成長の可能性も、市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。プロテアソーム阻害剤市場に関する当レポートの対象領域は以下の通りです。
- プロテアソーム阻害剤の市場サイジング
- プロテアソーム阻害剤の市場予測
- プロテアソーム阻害剤市場の産業分析
Technavioの強固なベンダー分析は、顧客が市場での地位を向上させることができるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Accuitis Inc.、Amgen Inc.、Bristol Myers Squibb Co.、Cantex Pharmaceuticals Inc.、Fresenius SE and Co.KGaA、ジョンソン・エンド・ジョンソン、武田薬品工業株式会社Ltd.、TGセラピューティック社）。また、プロテアソーム阻害剤市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/proteasome-inhibitors-market-industry-size-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 VELCADE - Market size and forecast 2021-2026
o Exhibit 28: Chart on VELCADE - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on VELCADE - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on VELCADE - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on VELCADE - Year-over-year growth 2021-2026 (%)
o 5.4 KYPROLIS - Market size and forecast 2021-2026
o Exhibit 32: Chart on KYPROLIS - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on KYPROLIS - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on KYPROLIS - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on KYPROLIS - Year-over-year growth 2021-2026 (%)
o 5.5 NINLARO - Market size and forecast 2021-2026
o Exhibit 36: Chart on NINLARO - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on NINLARO - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on NINLARO - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on NINLARO - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Product
o Exhibit 44: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.9 Germany - Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 France - Market size and forecast 2021-2026
o Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 93: AbbVie Inc. - Overview
o Exhibit 94: AbbVie Inc. - Product / Service
o Exhibit 95: AbbVie Inc. - Key offerings
o 10.4 Accuitis Inc.
o Exhibit 96: Accuitis Inc. - Overview
o Exhibit 97: Accuitis Inc. - Product / Service
o Exhibit 98: Accuitis Inc. - Key offerings
o 10.5 Amgen Inc.
o Exhibit 99: Amgen Inc. - Overview
o Exhibit 100: Amgen Inc. - Product / Service
o Exhibit 101: Amgen Inc. - Key offerings
o 10.6 Bristol Myers Squibb Co.
o Exhibit 102: Bristol Myers Squibb Co. - Overview
o Exhibit 103: Bristol Myers Squibb Co. - Product / Service
o Exhibit 104: Bristol Myers Squibb Co. - Key offerings
o 10.7 Cantex Pharmaceuticals Inc.
o Exhibit 105: Cantex Pharmaceuticals Inc. - Overview
o Exhibit 106: Cantex Pharmaceuticals Inc. - Product / Service
o Exhibit 107: Cantex Pharmaceuticals Inc. - Key news
o Exhibit 108: Cantex Pharmaceuticals Inc. - Key offerings
o 10.8 Fresenius SE and Co. KGaA
o Exhibit 109: Fresenius SE and Co. KGaA - Overview
o Exhibit 110: Fresenius SE and Co. KGaA - Business segments
o Exhibit 111: Fresenius SE and Co. KGaA - Key news
o Exhibit 112: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 113: Fresenius SE and Co. KGaA - Segment focus
o 10.9 Johnson and Johnson
o Exhibit 114: Johnson and Johnson - Overview
o Exhibit 115: Johnson and Johnson - Business segments
o Exhibit 116: Johnson and Johnson - Key news
o Exhibit 117: Johnson and Johnson - Key offerings
o Exhibit 118: Johnson and Johnson - Segment focus
o 10.10 Takeda Pharmaceutical Co. Ltd.
o Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 10.11 TG Therapeutics Inc.
o Exhibit 123: TG Therapeutics Inc. - Overview
o Exhibit 124: TG Therapeutics Inc. - Product / Service
o Exhibit 125: TG Therapeutics Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on VELCADE - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on VELCADE - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on VELCADE - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on VELCADE - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on KYPROLIS - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on KYPROLIS - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on KYPROLIS - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on KYPROLIS - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on NINLARO - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on NINLARO - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on NINLARO - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on NINLARO - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Product ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: AbbVie Inc. - Overview
Exhibits94: AbbVie Inc. - Product / Service
Exhibits95: AbbVie Inc. - Key offerings
Exhibits96: Accuitis Inc. - Overview
Exhibits97: Accuitis Inc. - Product / Service
Exhibits98: Accuitis Inc. - Key offerings
Exhibits99: Amgen Inc. - Overview
Exhibits100: Amgen Inc. - Product / Service
Exhibits101: Amgen Inc. - Key offerings
Exhibits102: Bristol Myers Squibb Co. - Overview
Exhibits103: Bristol Myers Squibb Co. - Product / Service
Exhibits104: Bristol Myers Squibb Co. - Key offerings
Exhibits105: Cantex Pharmaceuticals Inc. - Overview
Exhibits106: Cantex Pharmaceuticals Inc. - Product / Service
Exhibits107: Cantex Pharmaceuticals Inc. - Key news
Exhibits108: Cantex Pharmaceuticals Inc. - Key offerings
Exhibits109: Fresenius SE and Co. KGaA - Overview
Exhibits110: Fresenius SE and Co. KGaA - Business segments
Exhibits111: Fresenius SE and Co. KGaA - Key news
Exhibits112: Fresenius SE and Co. KGaA - Key offerings
Exhibits113: Fresenius SE and Co. KGaA - Segment focus
Exhibits114: Johnson and Johnson - Overview
Exhibits115: Johnson and Johnson - Business segments
Exhibits116: Johnson and Johnson - Key news
Exhibits117: Johnson and Johnson - Key offerings
Exhibits118: Johnson and Johnson - Segment focus
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits121: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits122: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits123: TG Therapeutics Inc. - Overview
Exhibits124: TG Therapeutics Inc. - Product / Service
Exhibits125: TG Therapeutics Inc. - Key offerings
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations